Researchers have identified a protein that powers the virulence of the bacteria that causes gonorrhea, opening the possibility of a new target for antibiotics and, even better, a vaccine.
The findings, published today in PLOS Pathogens, are especially important since the microbe, Neisseria gonorrhoeae, is considered a “superbug” because of its resistance to all classes of antibiotics available for treating infections.
Gonorrhea, a sexually transmitted disease that results in 78 million new cases worldwide each year, is highly damaging if untreated or improperly treated.
It can lead to endometritis, pelvic inflammatory disease, ectopic pregnancy, epididymitis and infertility. Babies born to infected mothers are at increased risk of blindness.
“The infections very often are silent,” said Oregon State University researcher Aleksandra Sikora. “Up to 50 percent of infected women don’t have symptoms, but those asymptomatic cases can still lead to some very severe consequences for the patient’s reproductive health, miscarriage or premature delivery.”
The need for better antibiotic therapy, and a vaccine, is pressing. N. gonorrhoeae strains resistant to the last effective treatment options have emerged, and failures in treatment are occurring.
Sikora and her research team at the OSU/OHSU College of Pharmacy and Ann Jerse’s lab at the Uniformed Services University of the Health Sciences in Bethesda, Maryland, collaborated to discover a novel lipoprotein that N. gonorrhoeae uses to defeat the body’s first line of innate immune defense.
The body relies on enzymes known as lysozymes that, as their name suggests, thwart bacteria by causing their cell wall to lyse, or break apart. Lysozymes are abundant both in epithelial cells, which make up the tissue on the outside of organs and the inside of body cavities, and in the phagocytic cells that protect the body by ingesting foreign particles and bacteria.
In turn, many gram-negative bacteria – characterized by their cell envelope that includes a protective outer membrane – have developed ways of defeating lysozymes. Prior to the work by Sikora’s team, however, only one lysozyme-fighting protein had been discovered in the Neisseria genus.
Now that new targets have been identified, they can be explored as bullseye candidates for new antibiotics or a vaccine – if the lysozyme inhibitor can itself be inhibited, then the bacteria’s infection-causing ability is greatly reduced.
Sikora and her collaborators named the new protein SliC, short for surface-exposed lysozyme inhibitor of c-type lysozyme.
Studying SliC’s function in culture as well as in a gonorrhea mouse model – mice were infected with N. gonorrhoeae, then checked for SliC expression at one, three and five days – researchers determined the protein was essential to bacterial colonization because of its anti-lysozyme role.
“This is the first time an animal model has been used to demonstrate a lysozyme inhibitor’s role in gonorrhea infection,” Sikora said. “Together, all of our experiments show how important the lysozyme inhibitor is. This is very exciting.”
The Latest on: Gonorrhea
via Google News
The Latest on: Gonorrhea
- Gonorrhea cases up dramatically on April 18, 2019 at 5:37 pm
ROCK FALLS – Parties resulting in anonymous sex appear to be driving a spike in gonorrhea cases, the Whiteside County Health Department says. In the first 3 months of this year, more cases of the ... […]
- Chlamydia, Syphilis and Gonorrhea on the rise in the Central West on April 18, 2019 at 4:30 pm
Western NSW Local Health District has revealed that last year 831 people in the Western Health District were notified they had contracted Chlamydia. A further 37 people were confirmed to be infected ... […]
- OSU researcher to help create gonorrhea vaccine on April 17, 2019 at 9:14 pm
CORVALLIS, Ore. - An Oregon State University scientist is part of a $10.7 million National Institutes of Health grant to develop a vaccine for gonorrhea. Aleksandra Sikora, a researcher with the OSU ... […]
- 20-Year-Old Develops Red Lesions on Her Hand After Having Unprotected Sex on April 17, 2019 at 2:40 pm
It turns out the rash was caused by gonorrhea that had spread to the patient's skin, according to a new case report in the New England Journal of Medicine. You might think of gonorrhea as a condition ... […]
- Woman develops gonorrhea rash on her hands and all over her skin on April 17, 2019 at 2:01 pm
A 20-year-old woman in the U.S. visited the emergency room after developing a rash all over her hands, arms, legs, trunk, and scalp. It turned out that the cause was gonorrhea. The young woman had ... […]
- Why the dramatic rise in sexually transmitted infections is a major wakeup call on April 17, 2019 at 10:56 am
So the question is, why are we seeing this increase?” Given that untreated STIs like chlamydia, gonorrhea, and syphilis can lead to some pretty dire consequences—including infertility, pelvic ... […]
- Reported STDs continue climb in North Dakota with a sharp rise in gonorrhea on April 16, 2019 at 7:21 pm
BISMARCK — The overall number of sexually transmitted diseases reported in North Dakota increased last year, according to new data from the North Dakota Department of Health, but one infection in ... […]
- STD rates continue to rise on April 16, 2019 at 4:38 am
Common STDs include chlamydia, HPV (human papillomavirus), gonorrhea, genital herpes, HIV and syphilis. “Statistics show that one in two sexually active young people will get an STD by age 25 — and ... […]
- STD Trends: Gonorrhea, Chlamydia numbers up in Iowa and nationally on April 4, 2019 at 6:15 am
For the most part, sexually transmitted disease diagnoses in Iowa continue to increase similar to national trends, according to 2018 data from the state Department of Public Health. The one exception ... […]
via Bing News